12 results
COVID-19 review…here is a list of some of the drugs that are currently being used or
COVID-19 review… ... most effective treatments ... #CoronaVirus #Treatment ... Pandemic #Outbreak #InfectiousDiseases ... Pharmacotherapy #Pharmacology
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
virus causing COVID ... ivermectin… #COVID19 ... Pandemic #Outbreak #InfectiousDiseases ... EmergencyMedicine #Pharmacology ... #Treatment #Virus
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
Antivirals #table #treatment ... #medications #infectiousdisease ... #hepatology #HepC ... HepatitisC #Management #Pharmacology
Azithromycin - since there has been a lot of noise around chloroquine/hydroxychloroquine, thought we can take
investigational treatments ... for COVID-19… ... Zithromax #Macrolides #InfectiousDiseases ... #COVID19 #Coronavirus ... #Pharmacology #
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the Treatment ... of COVID-19 Infection ... HCQ treatment would ... clinical trial Ever ... #COVID19 #Pharmacology
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
Pneumonia - Typhoid fever ... Corticosteroids #Adjuvant #InfectiousDiseases ... #Infections #Pharmacology ... #Management #Treatment
Systemic Therapy for Hepatocellular Carcinoma - AGA Clinical Practice Guideline

First Line Treatment for HCC with Preserved
First Line Treatment ... with Preserved Liver ... #Management #Hepatology ... Gastroenterology #oncology ... #Pharmacology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
interactions) Cancer-treatment ... #Chemotherapy #Oncology ... #Hematology #Interactions ... #Table #Pharmacology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Subacute-Acute: • Common: fever ... Renal Failure Treatment ... diagnosis #management #hematology ... #oncology
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
Presentation: • Fever ... index < 2 • EPO Level ... aplastic anemia Treatment ... Aplastic #Anemia #oncology ... #hematology #diagnosis